Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 44
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05872347 | Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases. | ||
| NCT05070156 | B010-A Injection for Treating Patients With GPC3 Positive Advanced Hepatocellular Carcinoma | ||
| NCT04066803 | Optimal MTX Dose With Folic Acid Randomized Case-control Trial | ||
| NCT06434610 | A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer. | ||
| NCT05245058 | SPH5030 Tablets in Subjects With Advanced Her2-positive Solid Tumors | ||
| NCT05944224 | A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors. | ||
| NCT06470191 | A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy. | ||
| NCT05770609 | A Study of SPH3127 in the Treatment of Mild to Moderate Ulcerative Colitis | ||
| NCT03953833 | B003 in Patients With HER2-positive Recurrent or Metastatic Breast Cancer | ||
| NCT06413654 | A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD) | ||
| NCT05046314 | A Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's Sarcoma | ||
| NCT06266923 | A Clinical Study of SPH6516 Tablets in the Treatment of Advanced Solid Tumors. | ||
| NCT05088070 | Clinical Study of SPH3348 Tablets, a C-Met Inhibitor, in Patients with Advanced Solid Tumors | ||
| NCT06483373 | A Clinical Study of SPH7854 Granules in Healthy Subjects. | ||
| NCT06434597 | A Clinical Study of SPH5030 Tablets in the Treatment of Her2-positive/Mutated Biliary Tract OR Colorectal Cancer Patients. | ||
| NCT05744687 | Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer | ||
| NCT05555706 | Study of B013 and Nab-Paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer | ||
| NCT06447597 | A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis. | ||
| NCT03332121 | B001 in Patients With CD20 Positive B-cell Non Hodgkin's Lymphoma | ||
| NCT03255993 | The Tolerability and Pharmacokinetics of Multiple Doses of SPH3127 in Chinese Healthy People | ||
| NCT05668403 | A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy | ||
| NCT05145361 | Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder (NMOSD) | ||
| NCT06454357 | A Clinical Study of B007 in the Treatment of Pemphigus. | ||
| NCT03756103 | Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients | ||
| NCT04382352 | B002 in Patients With HER2-positive Breast Cancer | ||
| NCT06839131 | A Clinical Study of SPH9788 Tablets in Healthy Chinese Subjects. | ||
| NCT02201043 | Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing Spondylitis | ||
| NCT05593562 | Study on Human Mass Balance of SPH3127 Tablets | ||
| NCT04084444 | Safety and Efficacy of T8 on Treating Chronic Abnormal Immune Activation in HIV/AIDS Patients | ||
| NCT05905614 | Phase I Clinical Study of SPH4336 Tablets in the Treatment of Advanced Solid Tumors | ||
| NCT02202395 | Hydroxytriptolide in Active Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate | ||
| NCT05359068 | Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension | ||
| NCT06372223 | A Food Effect Study of SPH5030 Tablets. | ||
| NCT03231475 | Phase I Study of SPH1188-11 in NSCLC | ||
| NCT05860465 | Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast Cancer | ||
| NCT05593575 | Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease | ||
| NCT06487455 | A Clinical Study of SPH7485 Tablets in the Treatment of Advanced Solid Tumors. | ||
| NCT03128138 | Single Ascending Dose Study of Safety and Tolerability of SPH3127 Tablet in Chinese Healthy Volunteers | ||
| NCT05359055 | Drug-drug Interaction Study of SPH3127 | ||
| NCT06214143 | A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With Advanced Solid Tumors | ||
| NCT06652997 | SPH3348 Tablets in a Single-center, Randomized, Open-label, Single-dose, Two-period, Two-sequence Crossover Design Food Effect Study in Healthy Chinese Subjects | ||
| NCT03249753 | The Effect of Food Intake on the Pharmacokinetic of Single Dose SPH3127 Tablets in Chinese Health Subjects | ||
| NCT06214156 | A Clinical Study of T3011 in Subjects With Advanced Melanoma | ||
| NCT05686642 | Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke |
